BioSpace News Archive

Policy

Governor Brown signs Assembly Bill 315

New law is a victory for patients, pharmacists

September 30, 2018
·
1 min read
FDA

Zimmer Biomet Spine Announces FDA Approval of Mobi-C® Cervical Disc Labeling Extension to Include Seven-Year Clinical Results

Labeling extension follows seven-year study, presented on multiple podiums and published in theInternational Journal of Spine Surgery

September 30, 2018
·
5 min read
82,000 Canadians raise $16.2 million to make breast cancer beatable through the Canadian Cancer Society CIBC Run for the Cure

Across the country today, more than 82,000 Canadians gathered in 56 different communities to take part in the Canadian Cancer Society CIBC Run for the Cure, raising an estimated $16.2 million for the breast cancer cause.

September 30, 2018
·
3 min read
Pharm Country

Tocagen Presents Preliminary Data from Toca 6 Trial Supportive of Immune Activation in Patients with Advanced Solid Tumors at CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference

Tocagen Inc. today is presenting data describing the tumor microenvironment and immunogenicity of Toca 511 (vocimagene amiretrorepvec) & Toca FC (flucytosine, extended-release) in patients with solid tumor malignancies at the International Cancer Immunotherapy Conference hosted by The Cancer Research Institute (CRI), the Association for Cancer Immunotherapy (CIMT), the European Academy of Tumor Immunology (EATI), and the American Association for Cancer Research (AACR) in New York City.

September 30, 2018
·
5 min read
Drug Development

Inotrem Announces Positive Results From the Phase IIa Study of Its Lead Compound, Nangibotide (LR12), in the Treatment of Septic Shock

The study demonstrated the safety and tolerability of its lead compound in patients suffering from septic shock

September 30, 2018
·
4 min read
Biotech Bay

New Study Confirms Mediterranean Diet Prevents a Leading Cause of Blindness

Research shows we can all eat our way to better eye health

September 30, 2018
·
3 min read